nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Capecitabine—esophageal cancer	0.501	0.665	CbGbCtD
Sulfisoxazole—CYP2C9—Cisplatin—esophageal cancer	0.252	0.335	CbGbCtD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS1—esophageal cancer	0.012	0.0556	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—ANXA1—esophageal cancer	0.0118	0.0545	CbGpPWpGaD
Sulfisoxazole—Sulfathiazole—CYP19A1—esophageal cancer	0.0108	0.352	CrCbGaD
Sulfisoxazole—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—esophageal cancer	0.00855	0.0396	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—esophageal cancer	0.00632	0.0293	CbGpPWpGaD
Sulfisoxazole—CYP2C9—CYP2E1 reactions—CYP2A6—esophageal cancer	0.00608	0.0282	CbGpPWpGaD
Sulfisoxazole—Sulfanilamide—CA2—esophageal cancer	0.00589	0.193	CrCbGaD
Sulfisoxazole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—esophageal cancer	0.00575	0.0267	CbGpPWpGaD
Sulfisoxazole—Sulfaphenazole—CYP2A6—esophageal cancer	0.00569	0.186	CrCbGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—NOS3—esophageal cancer	0.00466	0.0216	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—esophageal cancer	0.0046	0.0213	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2A6—esophageal cancer	0.00377	0.0175	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—PTGS1—esophageal cancer	0.00369	0.121	CrCbGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00362	0.0168	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00346	0.016	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00346	0.016	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—GNG7—esophageal cancer	0.00333	0.0154	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00324	0.015	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00308	0.0143	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ADCYAP1—esophageal cancer	0.00299	0.0139	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GNG7—esophageal cancer	0.00297	0.0138	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00292	0.0135	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CXCL2—esophageal cancer	0.00289	0.0134	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS1—esophageal cancer	0.00288	0.0944	CrCbGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—ANXA1—esophageal cancer	0.00272	0.0126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—ANXA1—esophageal cancer	0.00269	0.0125	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—SST—esophageal cancer	0.00262	0.0121	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.00259	0.012	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—GHRL—esophageal cancer	0.00258	0.012	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—GHRL—esophageal cancer	0.00255	0.0118	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00248	0.0115	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—esophageal cancer	0.00244	0.0113	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—esophageal cancer	0.00231	0.0107	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.0022	0.0102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00218	0.0101	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.00217	0.01	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL2—esophageal cancer	0.00194	0.00899	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.00192	0.00887	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—ANXA1—esophageal cancer	0.0018	0.00836	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00178	0.00825	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—esophageal cancer	0.00175	0.00813	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00172	0.00796	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00172	0.00795	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—GHRL—esophageal cancer	0.00171	0.00792	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ADCYAP1—esophageal cancer	0.00169	0.00783	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GNG7—esophageal cancer	0.00168	0.00777	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—esophageal cancer	0.00165	0.0539	CrCbGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00164	0.00758	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00157	0.00725	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00154	0.00716	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ADCYAP1—esophageal cancer	0.00154	0.00711	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CXCL2—esophageal cancer	0.00148	0.00685	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00146	0.00676	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GDI2—esophageal cancer	0.00141	0.00652	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—ANXA1—esophageal cancer	0.00137	0.00636	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00135	0.00625	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—SST—esophageal cancer	0.00134	0.00619	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GHRL—esophageal cancer	0.0013	0.00603	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00127	0.00588	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00126	0.00584	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00124	0.00577	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.0012	0.00557	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00119	0.00549	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.00117	0.00542	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.00116	0.00538	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKAP13—esophageal cancer	0.00109	0.00505	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00102	0.00474	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KMT2D—esophageal cancer	0.00102	0.00471	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.00102	0.00471	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PDE4D—esophageal cancer	0.000996	0.00462	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKAP13—esophageal cancer	0.000989	0.00458	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000962	0.00445	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GNG7—esophageal cancer	0.000948	0.00439	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000946	0.00438	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000933	0.00432	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADCYAP1—esophageal cancer	0.000907	0.0042	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PDE4D—esophageal cancer	0.000905	0.00419	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000879	0.00407	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000867	0.00402	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GNG7—esophageal cancer	0.000861	0.00399	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CXCL2—esophageal cancer	0.000835	0.00387	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—WWOX—esophageal cancer	0.00083	0.00384	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FKBP1A—esophageal cancer	0.000789	0.00366	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—ANXA1—esophageal cancer	0.000776	0.0036	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—WIF1—esophageal cancer	0.000771	0.00357	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CXCL2—esophageal cancer	0.000758	0.00351	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—SST—esophageal cancer	0.000755	0.0035	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GHRL—esophageal cancer	0.000736	0.00341	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000717	0.00332	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CSNK1A1—esophageal cancer	0.000712	0.0033	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—ANXA1—esophageal cancer	0.000705	0.00327	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—SST—esophageal cancer	0.000686	0.00318	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000682	0.00316	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000675	0.00313	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000674	0.00312	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GHRL—esophageal cancer	0.000668	0.0031	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PFN1—esophageal cancer	0.000666	0.00308	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000658	0.00305	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000655	0.00303	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000639	0.00296	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ELMO1—esophageal cancer	0.000598	0.00277	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000586	0.00271	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKAP13—esophageal cancer	0.000584	0.00271	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000543	0.00252	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000539	0.0025	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000536	0.00248	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PDE4D—esophageal cancer	0.000535	0.00248	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000524	0.00243	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000511	0.00237	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GNG7—esophageal cancer	0.000508	0.00236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000504	0.00233	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—XIAP—esophageal cancer	0.000476	0.00221	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CTNNA1—esophageal cancer	0.000451	0.00209	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CXCL2—esophageal cancer	0.000448	0.00208	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSME2—esophageal cancer	0.000418	0.00194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSME1—esophageal cancer	0.000418	0.00194	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ANXA1—esophageal cancer	0.000416	0.00193	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SST—esophageal cancer	0.000405	0.00188	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH3—esophageal cancer	0.000395	0.00183	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GHRL—esophageal cancer	0.000395	0.00183	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—FBXW7—esophageal cancer	0.000388	0.0018	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH2—esophageal cancer	0.000354	0.00164	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000354	0.00164	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFBR2—esophageal cancer	0.000314	0.00146	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000309	0.00143	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SMAD4—esophageal cancer	0.000297	0.00138	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000274	0.00127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000274	0.00127	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000245	0.00114	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HIF1A—esophageal cancer	0.000243	0.00113	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA1—esophageal cancer	0.000233	0.00108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.000233	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—KDR—esophageal cancer	0.000233	0.00108	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH1—esophageal cancer	0.000219	0.00102	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA2—esophageal cancer	0.000213	0.000989	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.000209	0.000966	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREBBP—esophageal cancer	0.000199	0.000921	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000198	0.000919	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000198	0.000919	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000196	0.000909	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—EGFR—esophageal cancer	0.000195	0.000905	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000187	0.000865	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—esophageal cancer	0.000178	0.000824	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000174	0.000806	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PIK3CA—esophageal cancer	0.000169	0.000785	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ERBB2—esophageal cancer	0.000166	0.000771	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000166	0.00077	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000162	0.000749	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000158	0.00073	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TPI1—esophageal cancer	0.00015	0.000697	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.00015	0.000697	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCND1—esophageal cancer	0.000147	0.000681	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000144	0.000668	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDKN1A—esophageal cancer	0.000142	0.000659	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.000139	0.000643	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000138	0.000637	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EP300—esophageal cancer	0.000135	0.000627	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000131	0.000606	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000123	0.000568	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MYC—esophageal cancer	0.000118	0.000546	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.000117	0.00054	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—EGFR—esophageal cancer	0.000115	0.000534	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000115	0.000534	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000115	0.000532	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ENO1—esophageal cancer	0.000109	0.000506	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.000109	0.000506	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSME1—esophageal cancer	0.000108	0.000499	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PSME2—esophageal cancer	0.000108	0.000499	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PIK3CA—esophageal cancer	0.0001	0.000464	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—esophageal cancer	9.69e-05	0.000449	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.4e-05	0.000436	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP1B1—esophageal cancer	9.29e-05	0.00043	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP19A1—esophageal cancer	8.73e-05	0.000405	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—esophageal cancer	7.97e-05	0.000369	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.82e-05	0.000362	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCB1—esophageal cancer	7.65e-05	0.000354	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.78e-05	0.000268	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.11e-05	0.000237	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—esophageal cancer	4.58e-05	0.000212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.19e-05	0.000194	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—EP300—esophageal cancer	3.48e-05	0.000161	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PIK3CA—esophageal cancer	2.58e-05	0.000119	CbGpPWpGaD
